Oncology is a type of medicine that refers to the diagnosis, treatment and prevention of different types of cancers like blood cancer, skin cancer, breast cancer, lung cancer and others.
This report contains market size and forecasts of Personalized Medicines In Oncology in Global, including the following market information:
Global Personalized Medicines In Oncology Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Personalized Medicines In Oncology market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Molecular Oncopathology Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Personalized Medicines In Oncology include Biotheranostics, Illumina, DNA Link, Genomic Health, Inc.(Exact Sciences), Cypher Genomics(Human Longevity, Inc.), Life Technologies Corporation(Thermo Fisher Scientific), Fulgent Genetics, Caris Life Sciences and Ariana Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Personalized Medicines In Oncology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Personalized Medicines In Oncology Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Personalized Medicines In Oncology Market Segment Percentages, by Type, 2021 (%)
Molecular Oncopathology
Genome Diagnostics
Radiation Therapy
Oncology Testing
Chemotherapy
Others
Global Personalized Medicines In Oncology Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Personalized Medicines In Oncology Market Segment Percentages, by Application, 2021 (%)
Research Centers
Governmental Institutions
Hospitals
Clinical Centers
Others
Global Personalized Medicines In Oncology Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Personalized Medicines In Oncology Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Personalized Medicines In Oncology revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Personalized Medicines In Oncology revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Biotheranostics
Illumina
DNA Link
Genomic Health, Inc.(Exact Sciences)
Cypher Genomics(Human Longevity, Inc.)
Life Technologies Corporation(Thermo Fisher Scientific)
Fulgent Genetics
Caris Life Sciences
Ariana Pharma
Abbott Laboratories
deCODE genetics
Exagen Inc